Abstract
Establishing reliable and time efficient pipelines for structural MRI segmentation, parcellation and surface reconstruction, is essential to explore the potential clinical applications of research-grade morphometry tools. The integration between deep-learning based methods for fast whole-brain segmentation and the well known surface reconstruction algorithms is a viable alternative to perform this task. In this work, we applied this idea with three deep-learning based cortical parcellation models, DeepSCAN, FastsurferCNN and QuickNAT. With a 11 min surface reconstruction pipeline, we evaluated the performance of each segmentation beyond the voxel-based approaches and dice coefficient comparison between the generated parcellation and Freesurfer’s established silver standard. To prove the concept, we performed a direct comparison between the morphological variables obtained by our methodology and Freesurfer. Using a synthetic dataset, we benchmark each reconstruction pipeline based on the similarity to the ground-truth surface and reproduction of the expected surface-based metrics. The most robust pipeline across the human dataset and closer to the synthetic ground truth was based on DeepSCAN segmentation, producing a reliable morphometric tool with a processing time realistic for clinical applications like diagnostics support in individuals.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by the Swiss National Science Foundation (SNF, grant 204593, "ScanOMetrics" project). C.R. and R.W. acknowledge other support by the SNF (grant CRSII5 180365, Swiss First project) and the NIH (grant R01NS107513, Enigma Parkinson).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data from ABDC, HCP, OASIS, Synthetic atrophy and Phantom of Bern datasets
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos